Nantahala Capital Management LLC 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management LLC | 3,068,031 9.900% | 2,229,497 (+265.88%) | Filing |
| 2023-02-14 5:06 pm Purchase | 2022-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management LLC | 838,534 9.900% | 187,525 (+28.81%) | Filing |
| 2022-02-14 08:22 am Unchanged | 2021-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management LLC | 651,009 12.200% | 0 (Unchanged) | Filing |
| 2021-07-12 4:01 pm Purchase | 2021-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management LLC | 651,009 12.200% | 126,252 (+24.06%) | Filing |
| 2021-02-12 3:22 pm Purchase | 2020-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management LLC | 524,757 9.900% | 239,562 (+84.00%) | Filing |
| 2020-02-14 12:24 pm Purchase | 2019-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management LLC | 285,195 9.600% | 285,195 (New Position) | Filing |